1. Market Research
  2. > Pharmaceutical Market Trends
Isolator based Aseptic Filling Systems Market, 2020-2030

Isolator based Aseptic Filling Systems Market, 2020-2030

  • October 2020
  • 170 pages
  • ID: 5995357
  • Format: PDF
  • Roots Analysis Private Ltd.

Summary

Table of Contents

INTRODUCTION
Fill / finish is considered a critical aspect of pharmaceutical manufacturing. It is, therefore, imperative for drug manufacturers to ensure that formulations enclosed in primary containers are safe for consumption / administration. Despite being well established, there are several concerns associated with the contemporary drug filling process, such as the risk of contamination, filling errors (inaccurate dose dispensation), and labelling-related issues. In fact, experts in the industry believe that around 80% of product recalls may be attributed to packaging-related concerns. Contamination is one of the key concerns related to fill / finish operations. To ensure the safety of consumers, a lot of effort is put into maintaining an aseptic environment during the fill / finish step. In this regard, manual intervention in filling lines is not only a threat to product safety (being more susceptible to contamination from contact with laborers), but also inefficient. Over the years, the growing complexity of modern pharmaceuticals (especially biologic drugs and complex small molecule APIs), has created a corresponding need for the automation of routine, repetitive tasks, such as fill / finish. As a result, the drug filling process is gradually becoming more demanding, in terms of specialized equipment and infrastructure, and handling expertise.

Over the past couple of decades, pharma equipment manufacturers have developed more efficient, reliable and cost-effective machinery, involving the required isolators and restricted access barrier systems (RABS), to their proprietary filling lines. Many of such systems are designed to eliminate the need for human intervention, thereby, addressing the risk of operator-associated contamination. In addition, the use of filling lines where parts of the equipment are individually isolated, has been associated with notable cost saving opportunities. In such cases, developers need not invest in large, high-end cleanrooms for housing such filling lines. Currently, over 130 isolator-based filling and closing systems are available in the market, and equipment developers are still engaged in further improvement efforts. Given that more than 5,000 biopharmaceutical product candidates are currently under development, the opportunity for aseptic fill / finish equipment developers is anticipated to continue to grow at a substantial pace over the next decade.

SCOPE OF THE REPORT
The ‘Isolator based Aseptic Filling Systems Market, 2020-2030’ report features an extensive study of the current landscape of isolator based aseptic filling systems and the future opportunities associated with such systems. It features an in-depth analysis, highlighting the capabilities of various stakeholders engaged in this domain. In addition to other elements, the report features:
A detailed assessment of the overall landscape of the isolator based aseptic filling systems, highlighting the contribution of industry players and providing information on various types of systems (filling, and turnkey solutions), scale of operation (clinical and commercial), system throughput, compatible primary containers (ampoules, bottles, capsules, cartridges, syringes, vials and others), type of formulation and range of fill volume.
An insightful competitiveness analysis of isolator based aseptic filling systems, taking into consideration the scale of operation, system throughput, compatible primary containers, type of formulation and other important product related specifications.
Elaborate profiles of companies offering isolator based aseptic filling systems. Each profile features a brief overview of the company, its financial information (if available), proprietary product(s), recent developments and an informed future outlook.
A discussion on general regulatory guidelines for aseptic processing, and specific recommendations related to isolator and blow / fill / seal technologies used in the aseptic fill / finish process.
An analysis of various developments / recent trends related to aseptic processing market, offering insights on [A] partnerships and collaborations established within the industry, and [B] conferences held in this space.

One of the key objectives of the report was to understand the primary growth drivers and estimate the future opportunity within the market. Based on several parameters, such as annual fill / finish pharma capacity, number of automatic filling lines installed and growth trends across various geographies, we have provided an informed estimate of the likely evolution of the market, in the mid to long term, for the period 2020-2030. The chapter features the likely distribution of the opportunity across [A] scale of operation (clinical and commercial), [B] type of compatible primary container (ampoules, bottles, capsules, cartridges, syringes, vials and others), [C] system throughput (low throughput, medium throughput and high throughput), [D] end-user (pharmaceutical companies, contract service providers and others) and [E] geographical regions (North America, Europe, Asia-Pacific and rest of the world). In order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution.

The opinions and insights presented in this study were influenced by discussions conducted with stakeholders in this domain.

All actual figures have been sourced and analyzed from publicly available information forums. Financial figures mentioned in this report are in USD, unless otherwise specified.

RESEARCH METHODOLOGY
The research, analysis and insights presented in this report are backed by a deep understanding of insights gathered from both secondary and primary sources. For all our projects, we conduct interviews with experts in the area (academia, industry and other associations) to solicit their opinions on emerging trends in the market. This is primarily useful for us to draw out our own opinion on how the market will evolve across different regions and technology segments. Where possible, the available data has been checked for accuracy from multiple sources of information.

The secondary sources of information include
Annual reports
Investor presentations
SEC filings
Industry databases
News releases from company websites
Government policy documents
Industry analysts’ views

While the focus has been on forecasting the market till 2030, the report also provides our independent view on various non-commercial trends emerging in the industry. This opinion is solely based on our knowledge, research and understanding of the relevant market gathered from various secondary and primary sources of information.

KEY QUESTIONS ANSWERED
Who are the leading isolator based aseptic filling system developers?
What are the recent developments in the aseptic processing domain?
What are the latest regulatory guidelines for aseptic fill / finish manufacturers?
What factors are likely to influence the evolution of this upcoming market?
How is the current and future opportunity likely to be distributed across key market segments?

CHAPTER OUTLINES
Chapter 2 is an executive summary of the insights captured in our research. It offers a high-level view on the likely evolution of the aseptic filling systems market in the mid to long term.

Chapter 3 provides an overview of drug fill / finish process, and various aseptic fill / finish techniques. It also highlights the need for aseptic fill / finish in drug manufacturing, and various traditional and advanced aseptic fill / finish techniques currently being used in the pharma industry. Further, the chapter highlights a comparison between isolator and RABS systems, as well as various advantages associated with the advanced aseptic fill / finish methods and its future perspectives.

Chapter 4 provides an overview of the overall landscape of the isolator based aseptic filling systems, highlighting the contribution of industry players and providing information on various types of systems (filling, and turnkey solutions), scale of operation (clinical and commercial), system throughput, compatible primary containers (ampoules, bottles, capsules, cartridges, syringes, vials and others), type of formulation and range of fill volume.

Chapter 5 provides a detailed insightful competitiveness analysis of isolator based aseptic filling systems, taking into consideration the scale of operation, system throughput, compatible primary containers, type of formulation and other important product related specifications.

Chapter 6 includes detailed profiles of the companies offering isolator based aseptic filling systems. Each profile features a brief overview of the company, its financial information (if available), proprietary product(s), recent developments and an informed future outlook.

Chapter 7 providers general regulatory guidelines for aseptic processing, and specific recommendations related to isolator and blow / fill / seal technologies used in the aseptic fill / finish process.

Chapter 8 provides an analysis of various developments / recent trends related to aseptic processing market, offering insights on [A] partnerships and collaborations established within the industry, and [B] conferences held in this space.

Chapter 9 presents a detailed market forecast, highlighting the distribution of the opportunity across [A] scale of operation (clinical and commercial), [B] type of compatible primary container (ampoules, bottles, capsules, cartridges, syringes, vials and others), [C] system throughput (low throughput, medium throughput and high throughput), [D] end-user (pharmaceutical companies, contract service providers and others) and [E] geographical regions (North America, Europe, Asia-Pacific and rest of the world).

Chapter 10 summarizes the entire report. It presents a list of key takeaways and offers our independent opinion on the current market scenario. Further, it summarizes the various evolutionary trends that are likely to influence the future of this market.

Chapter 11 is a collection of executive insight(s) of the discussion(s) that were held with key stakeholder(s) in this market.

Chapter 12 is an appendix, which provides tabulated data and numbers for all the figures included in the report.

Chapter 13 is an appendix, which contains the list of companies and organizations mentioned in the report.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Flow Imaging Microscopy/Dynamic Image Analysis Market by Type, Dispersion, Enduser - Global Forecast to 2025

  • $ 4950
  • January 2021
  • 121 pages

The global flow imaging microscopy market size is projected to reach USD 45 million by 2025 from USD 32 million in 2020, at a CAGR of 7.4%. The growth of the market is attributed to increasing investment ...

  • World
  • Europe
  • Pharmaceutical
  • Biotechnology
  • Industry analysis
  • Health Expenditure
  • Drug Approval

Global Campesterol Industry $ 5600 March 2021

Global Glutamic Acid Industry $ 5600 March 2021


ref:plp2020

Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on